Bone health and treatments
Bone health and treatments is a research topic within Oncology. Science Explorer counts 43k research works in it since 1950. 14.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the use of bisphosphonates in the treatment of bone metastases and associated complications, particularly osteonecrosis of the jaw. It explores the mechanisms of action, clinical features, and therapeutic opportunities for bisphosphonates in cancer treatment, with a specific emphasis on prostate and breast cancer. The papers also discuss the role of bisphosphonates in maintaining bone health and preventing skeletal complications in cancer patients.
- Bisphosphonates
- Osteonecrosis of the Jaw
- Bone Metastasis
- Cancer Treatment
- Skeletal Complications
- Mechanism of Action
- Metastatic Bone Disease
- Clinical Practice Guidelines
- Prostate Cancer
- Breast Cancer
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 6.2k per year above
- Top-10% rate
- 14.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -2% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Bone health and treatments research?
By volume, the United States and China publish the most (948 and 815 works in 2022–2025).
By volume, 2022–2025
- 1 United States 948 works
- 2 China 815 works
- 3 Japan 380 works
- 4 India 267 works
- 5 Italy 208 works
- 6 United Kingdom 192 works
- 7 Germany 182 works
- 8 Brazil 165 works
- 9 South Korea 162 works
- 10 Türkiye 142 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bone health and treatments research?
By volume in 2022–2025, Sichuan University publishes the most Bone health and treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Peking University.
By volume, 2022–2025
- 1 Sichuan University China 17 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical College China 16 works
- 3 Peking University China 14 works
- 4 Massachusetts General Hospital United States 14 works
- 5 Universidade de São Paulo Brazil 13 works
- 6 Harvard University United States 13 works
- 7 The University of Texas MD Anderson Cancer Center United States 12 works
- 8 University of Pennsylvania United States 12 works
- 9 Yonsei University South Korea 11 works
- 10 Nanjing Medical University China 11 works
Who are the leading researchers in Bone health and treatments?
The most-cited researchers publishing on Bone health and treatments include Cyrus Cooper.
- 1 Cyrus Cooper 7.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bone health and treatments research done?
The largest centres of Bone health and treatments research in 2022–2025 are Beijing (China), Tokyo (Japan), Seoul (South Korea) and Shanghai (China).
Largest cities, 2022–2025
Where is the best place to study Bone health and treatments?
Among universities, judged by research, Nagasaki University, Sichuan University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Nagasaki University Japan | 61.7 | 20.2% | 15.8× | 9 | +26.8% |
| 2 | Sichuan University China | 59.7 | 27.8% | 2.0× | 17 | +18.1% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 58.5 | 19.9% | 3.3× | 16 | +57.0% |
| 4 | University of Sheffield United Kingdom | 56.6 | 30.5% | 4.1× | 10 | -14.6% |
| 5 | Peking University China | 51.2 | 17.3% | 1.9× | 14 | +54.9% |
| 6 | Harvard University United States | 50.1 | 26.0% | 2.1× | 13 | -32.7% |
| 7 | Post Graduate Institute of Medical Education and Research India | 45.3 | 10.2% | 6.6× | 11 | +64.6% |
| 8 | Soochow University China | 43.9 | 27.1% | 2.1× | 8 | +47.2% |
| 9 | National and Kapodistrian University of Athens Greece | 40.2 | 11.9% | 3.9× | 10 | +47.4% |
| 10 | Shanghai Jiao Tong University China | 39.4 | 22.6% | 1.0× | 10 | +14.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Bone health and treatments research growing?
Output in 2018–2022 was 2% lower than in 2013–2017, peaking in 2013. The fastest-growing topics are Bone health and treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.